Plain-English translation of NCT07345585 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This trial is testing whether Lactobacillus rhamnosus GG, a type of probiotic (beneficial bacteria), can help children with autism spectrum disorder who also have digestive problems like constipation or diarrhea. The research is based on the idea that an imbalance in gut bacteria may play a role in autism, and restoring that balance with the medication might improve both digestive and behavioral symptoms. Half of the children will receive the probiotic, and half will receive a placebo (inactive pill) to see if there's a real difference.
Children with autism often have digestive problems that make their symptoms worse and affect their families' quality of life. Recent research suggests that an imbalance in gut bacteria may be connected to autism, so this treatment aims to restore healthy bacteria and potentially improve both digestive and autism-related symptoms.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join this study, your child will take either the probiotic supplement or a placebo pill daily for a set period. You'll have visits with the research team to monitor how your child is doing, answer questions about digestive and behavioral symptoms, and track any changes. The study is designed to be straightforward and fits into a family's normal routine while researchers collect information to see whether the medication helps.
AI-generated summary from trial data ยท Jun 26, 2026 ยท Not medical advice
Italy